Neonatal invasive candidiasis in Tunisian hospital: Incidence, risk factors, distribution of species and antifungal susceptibility

Mycoses

Volumn 55, Issue 6, 2012, Pages 493-500

  Ben Abdeljelil, J ^a   Saghrouni, F ^a   Nouri, S ^a   Geith, S ^a   Khammari, I ^a   Fathallah, A ^a   Sboui, H ^a   Ben Said M ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Antifungal susceptibility; Invasive candidiasis; Mortality; Neonates; Tunisia

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANTIBIOTIC THERAPY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLOOD CULTURE; BLOOD SAMPLING; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CATHETER INFECTION; CEREBROSPINAL FLUID; CESAREAN SECTION; CLAVISPORA LUSITANIAE; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INVASIVE CANDIDIASIS; LABORATORY TEST; LENGTH OF STAY; LIVER ABSCESS; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PERITONEAL FLUID; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPECIES DISTRIBUTION; TOTAL PARENTERAL NUTRITION; VAGINAL DELIVERY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TUNISIA;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGI;

EID: 84867558804     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02189.x     Document Type: Article

References (28)

1. Brissaud O, Tandonnet J, Guichoux J. Candidoses invasives en réanimation néonatale. Arch Pediatr 2011; 18: 22-32.
2. Benjamin DK Jr, Stoll BJ, Gantz MG et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010; 126: 865-73.
3. Rodriguez D, Almirante B, Park BJ et al. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J 2006; 25: 224-9.
4. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 2006; 117: 1680-7.
5. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-91.
6. Huang YC, Lin RI, Chou YH, Kuo CY, Yang PH, Hsieh WS. Candidaemia in special care nurseries: comparison of albicans and parapsilosis infection. J Infect 2000; 40: 171-5.
7. Benjamin DK Jr, Stoll BJ, Fanaroff AA et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality, and neurodevelopmental outcomes at 18-22months. Pediatrics 2006; 117: 84-92.
8. Kaufman DA. Challenging issues in neonatal candidiasis. Curr Med Res Opin 2010; 26: 1769-78.
9. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004; 17: 638-80.
10. Downey LC, Smith PB, Benjamin DK Jr, Cohen-Wolkowiez M. Recent advances in the detection of neonatal candidiasis. Curr Fungal Infect Rep 2010; 4: 17-22.
11. Ben AbdeljelilJ, Saghrouni F, Emira N et al. Molecular typing of Candida albicans isolates from patients and health care workers in a neonatal intensive care unit. J Appl Microbiol 2011; 111: 1235-49.
12. Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253-8.
13. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsåker T, Gaustad P. Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 2006; 44: 1977-81.
14. Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol 2010; 37: 611-28.
15. Poikonen E, Lyytikäinen O, Anttila VJ et al. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 2010; 10: 312.
16. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Candida parapsilosis infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2007; 92: 127-9.
17. Levy I, Rubin LG, Vasistha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidaemia in children. Clin Infect Dis 1998; 26: 1086-8.
18. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504-8.
19. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606-25.
20. Durussel C, Parreno D, Nougier L, Monnin V, Zambardi G, Bille J. Comparative study of various methods, NCCL M27-A2, EUCAST and ATB Fungus 2 (bioMérieux) for the in vitro antifungal susceptibility testing of Candida sp. Clin Microbiol Infect 2004; 10: 112-3.
21. Pfaller MA, Messer SA, Karlsson A, Bolmström A. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J Clin Microbiol 1998; 36: 2586-9.
22. Cantón E, Espinel-Ingroff A, Pemán J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther 2009; 7: 107-19.
23. Scholer HJ. Flucytosine. In: Speller DCE (ed.), Antifungal Chemotherapy. UK: Chichester, 1980: 35-106.
24. Pfaller MA, Messer SA, Boyken L, Huynh H, Hollis RJ, Diekema DJ. In vitro activities of 5-fluorocytosine against 8, 803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob Agents Chemother 2002; 46: 3518-21.
25. Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 2008; 46: 120-8.
26. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 2011; 49: 396-9.
27. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: Review of Epidemiology, Pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80-96.
28. Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103: 446-51.